Day Trading Reports
  • Business
  • World News
  • Politics
  • Investing
  • Business
  • World News
  • Politics
  • Investing

Day Trading Reports

World News

Prince Frederik of Luxembourg dies from rare disease

by admin March 10, 2025
March 10, 2025
Prince Frederik of Luxembourg dies from rare disease

Prince Frederik of Luxembourg has died after a lifelong battle with a rare genetic disorder known as POLG mitochondrial disease.

He passed away on March 1 in Paris, his family announced on the website of the POLG Foundation, which Frederik started in 2022.

“It is with a very heavy heart that my wife and I would like to inform you of the passing of our son, The POLG Foundation Founder and Creative Director, Frederik,” his father Prince Robert of Luxembourg wrote.

The foundation describes POLG as a “genetic mitochondrial disorder that robs the body’s cells of energy, in turn causing progressive multiple organ dysfunction and failure.”

It said the disease has no treatment or cure.

“Frederik and the POLG Foundation … are committed to finding therapies and a cure to save other patients from suffering what Frederik and our family have endured,” his father wrote.

Prince Frederik died a day after Rare Disease Day. He was in his early 20s.

This post appeared first on cnn.com

previous post
Why Argentina’s military is deploying to surveil hundreds of Chinese fishing boats off its coast
next post
Here’s why banks don’t want the CFPB to disappear

Related Posts

Trump administration reviewing Biden-era submarine pact with Australia,...

June 12, 2025

Argentina’s President Milei faces impeachment calls after promoting...

February 17, 2025

Severe wildfires in Russia’s Siberia region rage through...

May 15, 2025

Can NATO survive without the United States? The...

March 7, 2025

Ukraine ramps up calls for ‘pressure’ on Russia...

May 17, 2025

Owner of Dominican nightclub says plaster tiles often...

April 25, 2025

Elephant kills two female tourists from the UK...

July 5, 2025

Panama denies State Department claim US government vessels...

February 6, 2025

How the US threat to ‘move on’ from...

April 19, 2025

The baby at the heart of an investigation...

April 12, 2025

    Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Editors’ Picks

    • 1

      Forum Energy Metals and Global Uranium Announce Exploration Update on Drill Targeting, Northwest Athabasca Project, Saskatchewan

      January 31, 2025
    • 2

      Mega M&A: Rio Tinto-Glencore Merger Sparks Chatter

      January 28, 2025
    • 3

      Excellent 90% recoveries at Cork Tree Well & Board Update

      February 17, 2025
    • 4

      Netflix shares soar as company reports surging revenue, tops 300 million subscribers

      January 23, 2025
    • 5

      Financial Agreement signed releasing $2M grant

      January 23, 2025
    • 6

      Cyclopharm Signs US Agreement with HCA Healthcare for Technegas®

      January 23, 2025
    • 7

      FDA officially authorizes Zyn nicotine pouches for sale following health review

      January 23, 2025
    • About us
    • Contacts
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: daytradingreports.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2025 daytradingreports.com | All Rights Reserved